A Guide to State Licensing for 503B Outsourcing Facilities

A 503B outsourcing facility compounds sterile drugs in large quantities without patient-specific prescriptions and distributes to healthcare providers for office or hospital use.

While they do not require patient-specific prescriptions, they may only distribute to healthcare facilities and practitioners, not directly to patients or for retail pharmacy resale.

While FDA registration is relatively straightforward, state regulations governing 503Bs across all 50 states are not always uniform.

FDA Registration

A 503B facility must register with the FDA under Section 503B of the FD&C Act which gives a facility federal standing. This proves that the facility has met the requirements for current Good Manufacturing Practice compliance, FDA inspection, and a listing among FDA's registered outsourcing facilities.

What State License Type Does a 503B Need to Obtain?

In addition to FDA registration, the shipment of compounded product into a state requires a facility to obtain the license of that state.

Each state decides independently how to classify and license an outsourcing facility:

• Some states license 503Bs as a category of drug manufacturer, holding them to the same reporting and oversight standards as any other manufacturer in that state.
• Some require pharmacy registration, particularly once the facility dispenses to an individual patient.
• Some have built a distinct outsourcing facility permit specifically for 503Bs.

Confirm which category each state uses, and what that category actually demands, before filing your application.

Common License Application Requirements

Requirements vary by state, but most applications ask for a similar core set of documentation:

• Proof of FDA 503B registration: a copy of the facility's listing as a Registered Outsourcing Facility
• Current FDA inspection report: typically required within the prior 1 to 2 years, depending on the state
• Home state license or proof of exemption: evidence the facility is licensed elsewhere, or a written explanation if it isn't
• Ownership and organizational disclosures: a chart tracing legal business entities from the ultimate parent company down to the applicant, including legal name, trade name, tax ID, and ownership percentage for anyone holding 10% or more
• Pharmacist-in-Charge information: identity, license number, and in several states, a requirement that this person hold licensure in that specific state
• Written description of services: what the facility compounds and does at that location
• List of compounded products: every compound made at the applicant facility
• Sterile compounding SOPs: written procedures complying with USP Chapter <797> and current Good Manufacturing Practice
• Controlled substance registration: DEA registration, plus any state-specific controlled substance registration, if applicable
• Business authorization: proof of active registration with the relevant Secretary of State
• Existing license disclosures: other state permits held, and any disciplinary history

Important Nuances to Know Before You Apply

Inspections have a shelf life. States that accept a facility's FDA inspection in place of their own typically cap how old that inspection can be, often 6 months to 2 years. Once that window closes, the state will require a new inspection, either its own or from an approved third party, and the facility pays for it.

Dispensing to a patient can trigger pharmacy licensure. A 503B that occasionally dispenses under a patient-specific prescription can trigger a pharmacy licensure requirement in a state that otherwise treats it purely as an outsourcing facility or manufacturer. The outsourcing facility registration and a pharmacy license cover different activities and are not interchangeable.

Controlled substances. Facilities compounding controlled substances need DEA registration in addition to state licensure, and some states require their own controlled substance registration as well, independent of the outsourcing facility permit itself.

Avoiding Application Delays

Most application delays are preventable. These are the steps that make a difference.

• Confirm the correct license category for the state before starting
• Confirm whether a companion pharmacy, wholesale distributor, or manufacturer license applies in that state
• Verify the FDA registration and inspection report are both current enough for that state's window
• Make sure SOPs reflect actual current operations
• Confirm the Pharmacist-in-Charge's licensure before applying, not during review
• Assign one point of contact to track deadlines and board communications
• Build the ownership organizational chart early. It's consistently the most time-consuming document to assemble
• Respond to deficiency notices immediately. An unanswered application gets closed
• Apply months ahead of planned shipping dates to provide ample response time for unforeseen delays

Keeping Licenses Current

State licensing for 503B outsourcing facilities is not a one-time project. Requirements vary by state, license categorizations and definitions, and the consequences of a missing or lapsed license can disrupt operations and trading partner relationships.

The facilities that manage this well treat state licensing as an ongoing process. They track renewal deadlines, report changes promptly, and confirm that every state they ship into has a current, active license on file before product moves.

Getting licensed is the starting point. Staying licensed is the work.

Let LighthouseAI Help You Navigate 503B State Licensing

Determining which states require licensure, which license category applies, and what each application demands is a time-consuming and high-stakes process for 503B outsourcing facilities.

LighthouseAI's Rapid Assessments identify exactly where your facility needs to be licensed across all 56 US jurisdictions, so you can build a compliant licensing strategy from the ground up.

Contact Us Today‍